Wedbush Removes Zoll Medical (ZOLL) From 'Best Ideas List' Citing Lack of Near-Term Catalysts
Tweet Send to a Friend
Wedbush maintains an 'Outperform' on Zoll Medical (NASDAQ: ZOLL), PT $52.
Wedbush analyst says, "We believe ZOLL will lack the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "We believe ZOLL will lack the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
